社区人群中NT-proBNP浓度的性别与种族差异及心力衰竭绝对风险
本研究基于ARIC前瞻性队列,分析中晚年无心衰参与者的NT-proBNP浓度与心衰绝对风险。校正已知生理决定因素后,NT-proBNP的性别和种族差异仍持续存在,且相同NT-proBNP水平下的心衰绝对风险因性别和种族而异,黑种男性风险最高、白种女性最低。
要点
- NT-proBNP浓度在黑人男性最低、白人女性最高,校正生理因素后差异仍存在。
- 相同NT-proBNP水平下,心衰绝对风险因性别和种族不同而差异显著。
- 结合性别和种族解读NT-proBNP有助于更一致地预测心衰绝对风险。
核心结论
- 校正已知生理决定因素后,NT-proBNP浓度的性别和种族差异持续存在。
- 给定NT-proBNP值对应的心衰绝对风险因性别和种族而异,黑人男性风险较高、白人女性较低。
研究设计与样本
- 采用Cox和Poisson回归评估NT-proBNP与心衰相对及绝对风险,线性回归评估各因素对性别和种族差异的贡献。
主要发现
- visit 5时5191名无心衰参与者平均(SD)年龄76.0(5.2)岁,男性2104人(41%),黑人1043人(20%),NT-proBNP中位数(IQR)为124(64-239)pg/mL。
- 中年和晚年NT-proBNP中位数最低均为黑人男性(visit 2:30 [14-67] pg/mL;visit 5:74 [34-153] pg/mL),最高均为白人女性(visit 2:70 [42-111] pg/mL;visit 5:154 [82-268] pg/mL)。
- 在指南推荐阈值下,visit 2和visit 5的绝对风险率比分别为6.7(95%CI 4.6-9.9)和2.7(95%CI 1.7-4.1),黑人男性风险较高、白人女性较低。
- 结果在心血管健康研究队列中重复验证。
临床怎么用
- 临床解读NT-proBNP时应考虑性别和种族,以更一致地评估心衰绝对风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Sex- and race-based differences in N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations are poorly understood. Clinical decisions are often informed by absolute-as opposed to relative-risk, but absolute risk of incident heart failure (HF) associated with NT-proBNP concentration across these important demographic categories is unclear. OBJECTIVE: To determine whether physiologic determinants of NT-proBNP concentrations account for sex and race differences, and to more uniformly predict HF risk using NT-proBNP in these demographic subgroups. DESIGN, SETTING, AND PARTICIPANTS: In the longitudinal Atherosclerosis Risk in Communities epidemiologic prospective community-based cohort study, the association of NT-proBNP concentration with relative and absolute risk of HF by sex- and race-based categories was assessed at study visit 2 (1990-1992) and study visit 5 (2011-2013) using Cox and Poisson regression. These data were analyzed from June 2018 to October 2021. The contribution of clinical, anthropometric, echocardiographic, and laboratory parameters to sex- and race-based differences in NT-proBNP concentration was assessed at visit 5 using linear regression. Participants included were free of HF in midlife (visit 2; a total of 12 750 participants) and late life (visit 5; a total of 5191 participants). EXPOSURES: NT-proBNP concentration. MAIN OUTCOMES AND MEASURES: Incident HF or death. RESULTS: Among the 5191 HF-free participants at visit 5, the mean (SD) age was 76.0 (5.2) years, 2104 (41%) were male, 1043 (20%) were Black, and the median (IQR) NT-proBNP concentration was 124 (64-239) pg/. In both midlife and late life, NT-proBNP concentration was lowest in Black men (median [IQR] concentration: visit 2, 30 [14-67] pg/mL; visit 5, 74 [34-153] pg/mL) and highest in White women (median [IQR] concentration: visit 2, 70 [42-111] pg/mL; visit, 5, 154 [82-268] pg/mL). Sex and race differences in NT-proBNP concentration persisted after accounting for age, income, education, area deprivation index, cardiovascular diseases, left ventricular structure (LV), LV function, LV wall stress, weight and fat mass, and estimated glomerular filtration rate. Substantial differences in the absolute risk of incident HF or death existed across the sex- and race-based categories at any NT-proBNP concentration (eg, 7-fold [rate ratio, 6.7; 95% CI, 4.6-9.9] and 3-fold [rate ratio, 2.7; 95% CI, 1.7-4.1] difference at visit 2 and visit 5, respectively, at guideline-recommended thresholds) with higher risk consistently observed among Black men and lower risk in White women. Results were replicated in a cohort of participants from the Cardiovascular Health Study. CONCLUSIONS AND RELEVANCE: In this study, sex- and race-based differences in NT-proBNP persisted after accounting for known physiologic determinants. Absolute risk associated with a given value of NT-proBNP varied substantially by sex and race. Consideration of NT-proBNP values in the context of sex and race allows for more uniform prediction of absolute risk across important demographic subgroups.
引用
- Myhre, Claggett, Yu, et al. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community. JAMA Cardiol. 2022. PMID: 35476049. doi:10.1001/jamacardio.2022.0680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。